Low-dose flutamide for women with androgen excess: Anti-androgenic efficacy and hepatic safety

Journal of Endocrinological Investigation

Volumn 32, Issue 1, 2009, Pages 83-84

  de Zegher, F ^a   Ibanez L ^b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DROSPIRENONE; FLUTAMIDE; METFORMIN; PLACEBO;

ANTIANDROGEN THERAPY; ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; HIRSUTISM; HUMAN; HYPERANDROGENISM; LIVER FAILURE; LIVER TOXICITY; LOW DRUG DOSE; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY;

EID: 64549090025     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345685     Document Type: Article

References (20)

1. Labrie F, Dupont A, Giguere M, et al. Combination therapy with flutarnice and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer. Prog Clin Biol Res 1988, 260: 41-62.
2. Wysowski DK, Fourcroy JL. Flutarnide hepatotoxicity. J Urol 1996, 155: 209-12.
3. Ibáñez L, Jaramillo A, Ferrer A, de Zegher F. Absence of hepatotoxicity after long-term, low-dose flutamide in hyperandrogenic girls and young women. Hum Reprod 2005, 20: 1833-6.
4. Rosenfield RL. Hirsutism. N Engl J Med 2005, 353: 2578-88.
5. Martin KA, Chang RJ, Ehrmann DA, et al. Evaluation and treatment of hirsutism in premenopausal women: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2008, 93: 1105-20.
6. Calaf J, López E, Millet A, et al; the Spanish Working Group for Hirsutism. Long-term efficacy and tolerability of flutamide combined with oral contraception in moderate to severe hirsutism. A 12-month, double-blind, parallel clinical trial. J Clin Endocrinol Metab 2007, 92: 3446-52.
7. Ibáñez L, Valls C, Cabré S, de Zegher F. Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and anti-atherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide. J Clin Endocrinol Metab 2004, 89: 4716-20.
8. Osculati A, Castiglioni C. Fatal liver complications with flutamide. Lancet 2006, 367: 1140-1.
9. Moghetti P, Castello R, Negri C, et al. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior. Fertil Steril 1995, 64: 511-7.
10. Muderris II, Bayram F, Sahin Y, Kelestimur F. A comparison between two doses of flutamide (250 mg/d and 500 mg/d) in the treatment of hirsutism. Fertil Steril 1997, 68: 644-7.
11. Falsetti L, Gambera A, Legrenzi L, Iacobello C, Bugari G. Comparison of finasteride versus flutamide in the treatment of hirsutism. Eur J Endocrinol 1999, 141: 361-7.
12. Muderris II, Bayram F, Guven M. Treatment of hirsutism with lowest-dose flutamide (62.5 mg/day). Gynecol Endocrinol 2000,14: 38-41.
13. Venturoli S, Paradisi R, Bagnoli A, et al. Low-dose flutamide (125 mg/ day) as maintenance therapy in the treatment of hirsutism. Horm Res 2001, 56: 25-31.
14. Gambineri A, Patton L, Vaccina A, et al. Treatment with flutamide, metformin, and their combination added to a hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study. J Clin Endocrinol Metab 2006, 91: 3970-80.
15. Ong K, de Zegher F, Valls C, Dunger DB, Ibáñez L. Persisting benefits 12-18 months beyond discontinuation of pubertal metformin therapy in low-birthweight girls. Clin Endocrinol 2007, 67: 468-71.
16. Castelo-Branco C, Moyano D, Gómez O, Balasch J. Long-term safety and tolerability of flutamide for the treatment of hirsutism. Fertil Steril 2008, Mar 11 [Epub ahead of print]; doi: 10. 101 6/ j.fertnstert.2008.01.046.
17. Ibáñez L, López-Bermejo A, Diaz M, Enriquez G, Valls C, de Zegher F. Pioglitazone (7.5 mg/d) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high-molecular-weight adiponectin. Clin Endocrinol 2008, 68: 317-20.
18. Dikensoy E, Balat O, Pence S, Akcali C, Cicek H. The risk of hepatotoxicity during long-term and low-dose flutamide treatment in hirsutism. Arch Gynecol Obstet 2009, 279: 321-7.
19. Ibáñez L, de Zegher F. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women. Hum Reprod Update 2006, 12: 243-52.
20. Ibáñez L, López-Bermejo A, del Rio L, Enríquez G, Valls C, de Zegher F. Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess. J Clin Endocrinol Metab 2007, 92: 1710-4.